Literature DB >> 18510629

Pulmonary hypertension in patients with bronchiolitis obliterans syndrome listed for retransplantation.

S D Nathan1, O A Shlobin, S Ahmad, S D Barnett, N A Burton, M T Gladwin, R F Machado.   

Abstract

Bronchiolitis Obliterans Syndrome (BOS) is a major cause of morbidity and mortality post-lung transplantation. Pulmonary hypertension (PH) may complicate the course of patients with advanced lung disease. We sought to characterize the prevalence of PH in patients with BOS. We performed a retrospective analysis of lung transplant recipients with BOS relisted for transplantation with the United Network for Organ Sharing (UNOS). Right heart catheterization (RHC) data were required for analysis. Eighty patients with BOS qualified for the analysis. PH was present in 32.5% of patients with an average mean pulmonary artery pressure (mPAP) of 32.3 mmHg (range: 26-63 mmHg). Of these, 42.3% had an elevated pulmonary capillary wedge pressure. There was no difference in PH prevalence between bilateral (26.5%) and single lung recipients (41.9%), nor did it differ by primary disease. There was no correlation between pulmonary function data and the presence or severity of PH. There was no difference in oxygen requirements or 6-min walk distance between patients with and without PH. This is the first report of PH in patients with BOS. Many of these cases occur in association with diastolic dysfunction. Although no impact on functional status or outcomes was discerned, further studies appear warranted.

Entities:  

Mesh:

Year:  2008        PMID: 18510629     DOI: 10.1111/j.1600-6143.2008.02277.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  4 in total

1.  Pulmonary hypertension associated with bronchiolitis obliterans after hematopoietic stem cell transplantation.

Authors:  A Pate; S Rotz; M Warren; R Hirsch; M Cash; K C Myers; J El-Bietar; A Nelson; G Wallace; A H Filipovich; J Bleesing; R S Chima; S M Davies; S Jodele; C E Dandoy
Journal:  Bone Marrow Transplant       Date:  2015-10-19       Impact factor: 5.483

2.  Pulmonary vascular changes 22 years after single lung transplantation for pulmonary arterial hypertension: a case report with molecular and pathological analysis.

Authors:  Yidan D Zhao; Jenny Peng; Elise Granton; Kathleen Lin; Catherine Lu; Licun Wu; Tiago Machuca; Thomas K Waddell; Shaf Keshavjee; Marc de Perrot
Journal:  Pulm Circ       Date:  2015-12       Impact factor: 3.017

3.  Pulmonary hypertension before first and second lung transplantation.

Authors:  Adriano R Tonelli; Irina Timofte; Omar A Minai; Maher Baz; Olufemi Akindipe
Journal:  Clin Transplant       Date:  2012-02-10       Impact factor: 2.863

Review 4.  A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children.

Authors:  Lama Elbahlawan; Ashok Srinivasan; R Ray Morrison
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-25       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.